[ARWR] QoQ Quarter Result on 30-Sep-2022 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
28-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q4]
Profit Trend
QoQ- -20.73%
YoY- -35.61%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 15,825 146,267 62,546 31,575 32,412 151,805 27,439 -30.78%
PBT -103,383 47,676 -41,794 -82,157 -72,046 44,366 -62,872 39.44%
Tax 742 -999 17 3,785 -863 -2,813 -1,156 -
NP -102,946 48,675 -41,811 -85,942 -71,183 44,366 -62,872 39.04%
Tax Rate - 2.10% - - - 6.34% - -
Total Cost 118,771 97,592 104,357 117,517 103,595 107,439 90,311 20.09%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -650.53 33.28 -66.85 -272.18 -219.62 29.23 -229.13 100.88%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.96 0.46 -0.39 -0.81 -0.67 0.42 -0.60 36.91%
EPS Diluted -0.96 0.45 -0.39 -0.81 -0.67 0.41 -0.60 36.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.